The effect of the prostaglandin-inhibitor naproxen on the endothelial cell-loss after cataract extraction.

The influence of the anti-inflammatory, prostaglandin-inhibitor naproxen on the endothelial cell-loss after cataract-surgery was studied. Twenty-six patients received the drug, and 27 comprised a control group. The cell-loss, estimated one year after surgery, was found to be significantly lower in the naproxen-treated group than in the control group.